Form 6-K Zhengye Biotechnology For: Jul 21

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of July 2026

 

Commission File Number: 001-42450

 

Zhengye Biotechnology Holding Limited

 

No. 1 Lianmeng Road, Jilin Economic & Technical Development Zone

Jilin City, Jilin Province, China

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒ Form 40-F ☐

 

 

 

Explanatory Note

 

Zhengye Biotechnology Holding Limited (the “Company”) issued a press release on July 21, 2026, announcing the Company’s comments in response to recent unusual trading activity in the price and trading volume of its Class A ordinary shares. A copy of this press release is attached hereto as Exhibit 99.1, and is incorporated by reference herein.

 

 

EXHIBIT INDEX

 

Exhibit No.		Description
99.1		Press release — Zhengye Biotechnology Holding Limited Comments on Unusual Trading Activity

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated: July 21, 2026

  

	Zhengye Biotechnology Holding Limited
	By:	/s/ Songlin Song
	Name:	Songlin Song
	Title:	Chief Executive Officer

 

 

ATTACHMENTS / EXHIBITS

PRESS RELEASE - ZHENGYE BIOTECHNOLOGY HOLDING LIMITED COMMENTS ON UNUSUAL TRADING ACTIVITY

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• RitFit's New Panther Machine Targets the Overlooked Muscles Behind Stronger Glutes, Faster Sprints, and Healthier Hips
• Political 360 Now Taps Aristotle's 235M Voter Records
• Nocpix Nature Launches Rovex, a Large-Screen Thermal Solution for Faster Bird Discovery